Yellow Wood Partners to acquire Dr. Scholl’s from Bayer

World |  News | 0 Comment | 23 Jul, 2019

Yellow Wood Partners has entered into a definitive agreement to buy the Dr. Scholl’s™ business from Bayer for a purchase price of 585 million U.S. dollars.  Dr. Scholl&rsq...Read more

WHO recommends dolutegravir as preferred HIV treatment option

World |  News | 0 Comment | 23 Jul, 2019

Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations, ...Read more

Medicxi closes €400m Fund (Medicxi III)

World |  News | 0 Comment | 22 Jul, 2019

Leading European life sciences investment firm Medicxi has announced the closing of Medicxi III, a new €400 million fund. This brings the total amount raised by Medicxi in the last thr...Read more

Merck and Broad Institute announce CRISPR license framework

World |  News | 0 Comment | 19 Jul, 2019

Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) have announced an agreement to offer non-exclusive li...Read more

TraceLink partners with Excellis Health Solutions

World |  News | 0 Comment | 18 Jul, 2019

TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes has announced a partnership with Excellis Hea...Read more

Chad Mirkin wins Kabiller Prize in nanoscience and nanomedicine

World |  News | 0 Comment | 16 Jul, 2019

Exicure, a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) constructs has announced Co-founder Chad A. Mirkin has been awarded the $250,00...Read more

Recursion Pharmaceuticals secures $121M in Series C funding

World |  News | 0 Comment | 16 Jul, 2019

Recursion, a next-gen biopharma company combining automated, experimental biology with artificial intelligence to discover and develop drugs at scale has announced the closing of a $121 mil...Read more

Illumina expands Genomics Accelerator to Cambridge, UK

World |  News | 0 Comment | 16 Jul, 2019

Illumina has announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the San Francisco Bay Area in 2014, Illumina Accelerator is a company creat...Read more

Gilead Sciences, Renown Institute for Health Innovation collaborate for NASH

World |  News | 0 Comment | 16 Jul, 2019

Gilead Sciences and the Renown Institute for Health Innovation (IHI) have announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance...Read more

J&J announces PPP for Investigational Prophylactic HIV Vaccine

World |  News | 0 Comment | 16 Jul, 2019

Johnson & Johnson has announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutical Companies, together with a consortium of global partners are preparing to ...Read more

Michigan scientists develop EpiPen to heal spinal cord injuries

World |  News | 0 Comment | 16 Jul, 2019

An injection of nanoparticles can prevent the body’s immune system from overreacting to trauma, potentially preventing some spinal cord injuries from resulting in paralysis. The appr...Read more

Abbott gets FDA approval for Alinity™ s System

World |  News | 0 Comment | 15 Jul, 2019

Abbott has announced that U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System.  This new solution will bring the latest scre...Read more

Gilead Sciences, Galapagos enter into deal worth $5B

World |  News | 0 Comment | 15 Jul, 2019

US based Gilead Sciences and Belgian firm Galapagos have announced that they have entered into a 10-year global research and development collaboration. Through this agreement...Read more

Certara forms new practice area to achieve health equity

World |  News | 0 Comment | 15 Jul, 2019

Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, has announced that it has formed a new practice area ...Read more

SOTIO initiates first-in-human clinical trial with IL-15 superagonist SO-C101

World |  News | 0 Comment | 12 Jul, 2019

SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with SO-C101, a superagonist fusion protein of interleukin IL-15. The pha...Read more

Celsius and J&J sign R&D collaboration agreement

World |  News | 0 Comment | 10 Jul, 2019

Celsius Therapeutics, a company focused on the discovery and development of precision therapeutics for patients with autoimmune diseases and cancer has announced a collaboration with Jansse...Read more

Sandoz launches oncology generic gefitinib in 13 EU countries

World |  News | 0 Comment | 10 Jul, 2019

Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally advanced or metastatic non-small cell lung cancer with activating mutati...Read more

DTC genetic testing market size to exceed $2.5bn by 2025

World |  Analysis | 0 Comment | 10 Jul, 2019

Increasing prevalence of rare genetic disorders globally coupled with extensive applications of direct-to-consumer genetic testing in early detection of cancer and other genetic disorder wi...Read more